Global Menopausal Hot Flashes Market 2017-2021
About Menopausal Hot Flashes
Menopausal hot flashes are the symptoms of menopause. They refer to feelings of warmth occurring during menopause transition (which includes stages such as premenopause, perimenopause, and postmenopause). Hot flashes cause redness of the skin (known as flushing) and excessive sweating. The menopausal hot flashes market is growing moderately at the rate of 3.01% owing to the increase in aging population globally, especially in Western countries, such as the US, which is likely to increase the menopause and post menopause-related cases.
Technavio’s analysts forecast the global menopausal hot flashes market to grow at a CAGR of 3.01% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global menopausal hot flashes market for 2017-2021. To calculate the market size, the report considers the revenue generated from the menopausal hot flashes solutions.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Menopausal Hot Flashes Market 2017-2021
Technavio recognizes the following companies as the key players in the global menopausal hot flashes market: ALLERGAN, Bayer, and Pfizer.
Other Prominent Vendors in the market are: Hisamitsu Pharmaceutical, iHealth Labs, Novo Nordisk, and Novartis.
Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is increasing awareness through social media marketing. The rise in awareness about menopause and its symptoms through social media initiatives has equipped women to handle that stage better. An increase in the number of social network users globally is encouraging vendors and marketers to invest in social media marketing to increase sales and maximize profits. With many educated, young adult women using social networking sites, there is a significant opportunity for vendors and the governing bodies to utilize the internet and create awareness.”
According to the report, one of the major drivers for this market is change in lifestyle. In recent years, there has been a significant change in the lifestyles of people characterized by unhealthy food habits, consumption of alcohol, and smoking. Generally, smoking has antiestrogen effects in women that can contribute to early menopause. Women these days are increasingly indulging in adventurous activities and sports, including adventure treks, swimming, running, and working out. Although these activities have valuable effects on mood and cardiovascular and bone health, there is very little evidence that suggests these activities help in managing vasomotor instability symptoms, including hot flashes and night sweats.
Further, the report states that one of the major factors hindering the growth of this market is side effects. Though women's health products are increasingly becoming available, consumers are concerned about the negative side effects of these products. Through mediums such as the internet, the side effects of menopausal solutions like HRT are coming to light. Many prescription therapies for hot flashes, including venlafaxine (Effexor) and desvenlafaxine (Pristiq), are known to cause side effects, such as a change in bowel habits, nausea, and headache.
ALLERGAN, Bayer, Pfizer, Hisamitsu Pharmaceutical, iHealth Labs, Novo Nordisk, and Novartis.